This looks fun and I’m going to try to attend.
New Limit is one of the most interesting longevity companies in the market, funded by Brian Armstrong of Coinbase fame. More details on company: https://www.newlimit.com , and recent press from last year: NewLimit, co-founded by Coinbase CEO Brian Armstrong, raises $40M to extend life | TechCrunch
May 23rd, 2024 in South San Francisco .
2024 May Progress Update - Live Event!
The days are long, the years are short
We’ll be hosting our second annual Progress Update live event on May 23rd, 2024 in South San Francisco .
We’ll be livestreaming the update, and also welcoming guests to join us on site. If you’re interested in attending in person, apply through the form below.
Until then, check out our previous 2023 Progress Update event at livestream.newlimit.com. That link will also host our 2024 Update as the date gets closer.
Background:
Having recently raised $40 million in a series A funding round, New Limit is another anti-aging biotech startup looking to develop epigenetic reprogramming therapies to treat age-related diseases with large unmet needs.
In order to reverse cellular aging in this manner, the company wants to use new epigenetics tools to reprogram cells so that they act younger, with an initial focus on T cells. To achieve this, it is taking advantage of great advancements in single cell genomics, epigenetic editing, and machine learning, which it says will help it overcome traditional roadblocks to epigenetic reprogramming. One of the main challenges for the company is figuring out how to shrink the functional performance delta between actual young cells and reprogrammed old ones.
Source: Eight anti-aging biotech companies on a mission to extend lives